1,152
Views
37
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

LncRNA17A regulates autophagy and apoptosis of SH-SY5Y cell line as an in vitro model for Alzheimer’s disease

, &
Pages 609-621 | Received 11 Aug 2018, Accepted 11 Dec 2018, Published online: 17 Jan 2019

References

  • Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer’s disease: past, present and future. Neuropharmacology. 2014;76:27–50.
  • Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356.
  • De Strooper B, Annaert W. Novel research horizons for presenilins and γ-secretases in cell biology and disease. Annu Rev Cell Dev Biol. 2010;26:235–260.
  • Janssen JC, Beck JA, Campbell TA, et al. Early onset familial Alzheimer’s disease: mutation frequency in 31 families. (ABN Abstracts). J Neurol Neurosurg Psychiatry. 2002;73(2):219–220.
  • Gellert P, Ponomareva Y, Braun T, et al. Noncoder: a web interface for exon array-based detection of long non-coding RNAs. Nucleic Acids Res. 2012;41(1):e20–e20.
  • Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484–1488.
  • Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010;1338:20–35.
  • Salta E, Strooper BD. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 2012;11:189–200.
  • Mus E, Hof PR, Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer’s disease. Proc Nat Acad Sci USA. 2007;104(25):10679–10684.
  • Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discovery. 2011;10(9):698–712.
  • Wirths O, Multhaup G, Bayer TA. A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide–the first step of a fatal cascade. J Neurochem. 2004;91(3):513–520.
  • Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase. Nat Med. 2008;14(7):723–730.
  • Modi PK, Jaiswal S, Sharma P. Regulation of neuronal cell cycle and apoptosis by microRNA 34a. Mol Cell Biol. 2016;36(1):84–94.
  • Massone S, Vassallo I, Fiorino G, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis. 2011;41(2):308–317.
  • Fatemi SH, Folsom TD, Reutiman TJ, et al. Expression of GABA B receptors is altered in brains of subjects with autism. Cerebellum. 2009 Mar 1;8(1):64–69.
  • Chu DC, Penney JB Jr, Young AB. Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer’s disease. Neurosci Lett. 1987;82(3):246–252.
  • Brown JT, Davies CH, Randall AD. Synaptic activation of GABAB receptors regulates neuronal network activity and entrainment. Eur J Neurosci. 2007;25(10):2982–2990.
  • Haughey NJ, Nath A, Chan SL, et al. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer’s disease. J Neurochem. 2002;83(6):1509–1524.
  • Tanida I, Minematsu-Ikeguchi N, Ueno T, et al. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1(2):84–91.
  • Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol. 2005;20(2):665–671.
  • Wiese C, Rolletschek A, Kania G, et al. Nestin expression–a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004;61(19–20):2510–2522.
  • Isobe I, Yanagisawa K, Michikawa M. A possible model of senile plaques using synthetic amyloid β-protein and rat glial culture. Exp Neurol. 2000;162(1):51–60.
  • Boland B, Kumar A, Lee S, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci. 2008;28:6926–6937.
  • Maoz R, Garfinkel BP, Soreq H. Alzheimer’s disease and ncRNAs. In: Neuroepigenomics in aging and disease. Cham: Springer; 2017. p. 337–361.
  • Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101.
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
  • Briggs JA, Wolvetang EJ, Mattick JS, et al. Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron. 2015;88(5):861–877.
  • Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J Neurosci. 1998;18(8):2801–2807.
  • Webber KM, Raina AK, Marlatt MW, et al. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech Ageing Dev. 2005;126(10):1019–1025.
  • Klein WL, Krafft GA, Finch CE. Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci. 2001;24(4):219–224.
  • Iwakiri M, Mizukami K, Ikonomovic MD, et al. An immunohistochemical study of GABAA receptor gamma subunits in Alzheimer’s disease hippocampus: relationship to neurofibrillary tangle progression. Neuropathology. 2009;29(3):263–269.
  • Kuhn SA, van Landeghem FK, Zacharias R, et al. Microglia express GABAB receptors to modulate interleukin release. Mol Cell Neurosci. 2004;25(2):312–322.
  • Cuervo AM, Bergamini E, Brunk UT, et al. Autophagy and aging: the importance of maintaining” clean” cells. Autophagy. 2005;1(3):131–140.
  • Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex. 1991;1(1):103–116.
  • Zeng Q, Zheng M, Zhang T, et al. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer’s disease. Neuroscience. 2016;314:64–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.